Plasma or serum free thyroxine (T 4 ) was measured by a novel nonisotopic, two-step immunossay in 373 consecutive patients attending a thyroid clinic, in whom thyroid status was categorized according to clinical findings, supported by routine thyroid function tests. The 95% confidence limit of free T 4 in the euthyroid patients (n = 112) was 7-20 pmol/L. Free T 4 concentrations within the reference range were found in six of 40 patients with primary hypothyroidism and nine of 182 patients with overt thyrotoxicosis, six of whom had T J toxicosis. Serum or plasma free T 4 measured by the two-step method showed improved diagnostic specificity over an analogue RIA in selected groups of euthyroid patients in whom abnormal binding of analogue T 4 can affect the validity of the result. Free T 4 results found by analogue RIA and the two-step method in 58 patients who were receiving thyroxine replacement therapy were similar. The between-assay precision of the two-step method was poor ranging from a coefficient of variation of 9·7% to 19·3% over a free T 4 concentration range of 5·0 to 46·0 pmol/L, We conclude that the two-step methodology offers diagnostic advantages for a laboratory which receives specimens from such patients for exclusion of thyroid disease but that improved assay precision is required before it could be used in a routine situation.
Since the introduction of the analogue radioimmunoassay (RIA) for free thyroxine (T 4 ) in 1981 such assays have found widespread use in the clinical chemistry laboratory. I The analogue RIA methods produce results that agree well with the reference method of equilibrium dialysis in patients attending thyroid clinics and appear to offer a significant improvement in diagnostic efficiency particularly in patients with minor alterations in concentrations of thyroxine binding globulin (TBG). [2] [3] [4] With increased use, however, it has become apparent that in some situations free T 4 results obtained by analogue RIA differ from those obtained by alternative methods, such as equilibrium dialysis. In severe non-thyroidal illness and particularly in chronic renal failure (CRF), free T 4 results by analogue RIA are often low whilst normal or raised levels Correspondence: Dr G J Beckett. may be found in the same situations using equilibrium dialysis.r '
Patients with low albumin concentrations or increased levels of non-esterified fatty acids (NEFA) frequently have low free T 4 concentrations measured by analogue RIA. The addition of albumin or NEFA to plasma in vitro produces an increase or decrease, respectively, in free T 4 when measured by analogue RIA. These effects are contrary to the predicted effects of the substances on free T 4 in plasma.":" Subnormal free T 4 concentrations have also been found by analogue RIA in a proportion of patients receiving anti-epileptic drugs," and in pregnancy when up to 20% of women had subnormal free T 4 in the third trimester of pregnancy.v":" The presence in serum of genetic variants of albumin that have high affinity for the T 4 analogue.P:'? or the presence of T 4 autoantibodies'<" produce artefacts in the analogue assays resulting in spurious 581 elevations of the free T 4 concentration. These findings have led to the suggestion that analogue methods should not be used by diagnostic laboratories."
There are several alternatives to analogue RIA for the measurement of free T 4 in plasma or serum. One of these is a two-step method," in which plasma or serum is first incubated with an insolubilized antibody, some of the free T 4 is adsorbed and the sample, together with interfering substances such as autoantibodies, is washed away. In the second step, labelled T 4 is added; this binds to vacant binding sites and excess label is then washed away. The label bound to the antibody is thus inversely proportional to the original free T 4 concentration. Although twostep assays are technically more demanding than analogue methods, their validity has not been seriously questioned." In addition, results appear to agree closely with those of equilibrium dialysis methods in specimens from patients with non-thyroidal illness and in the presence of increased NEFA. [25] [26] [27] [28] The two-step assays presently available use isotopic labels and tend to have poor precision and sensitivity at the low range of the assay." In this study we used a novel two-step assay carried out on micro titre plates and with a colorimetric end-point for measurement of free T 4 in serum from 373 consecutive patients attending a thyroid clinic. In addition, the diagnostic specificity of the two-step assay was compared with that of an analogue RIA in hypothyroid patients receiving thyroxine and in groups of euthyroid patients in whom spurious free T4 can arise due to binding of the T 4 analogue to components of plasma or serum.
PATIENTS
The following patient groups were studied. Serum or plasma was stored at -20°C before analysis.
Thyroid clinic patients
We studied 373 patients who presented consecutively to a thyroid clinic. The patients were all examined by a Consultant Endocrinologist (ADT) and thyroid status was categorized on the basis of clinical findings supported by routine thyroid function tests consisting of total T 3 and T 4 concentration, basal TSH concentration by a sensitive immunoradiometric assay, TRH test, TSH receptor antibodies and an 131I_uptake and scan as appropriate.
Forty patients had overt hypothyroidism, eight had subclinical hypothyroidism, 112 were euthyroid, 18 were euthyroid and taking an oestrogen-containing oral contraceptive pill (OCP), 13 had subclinical hyperthyroidism and 182 were overtly hyperthyroid.
Patients with abnormal binding proteins Familial dysalbuminaemic hyperthyroxinaemia
In seven of 17 patients with familial dysalbuminaemic hyperthyroxinaemia (FDH) the protein abnormality was confirmed by electrophoresis and the T 4 loading test;29.30 in the remaining 10 patients the abnormality was confirmed by a T4 loading test alone. Two of the patients were taking thyroxine, one patient was taking carbimazole, whilst the remainder were euthyroid.
Patients with TBG abnormalities
The serum TBG concentration was increased in 14 patients, ranging from 25-56 mg/L (reference range 7-18'5mg/L) and decreased (4mg/L) in one subject.
T 4 autoantibodies
Serum from nine patients contained T 4 autoantibodies and in three, serum also contained T 3 autoantibodies. Seven patients were taking thyroxine and two were euthyroid.
Pregnancy
Sera from 59 women were studied; 24 women were in the first trimester, four in the second, and 31 in the third trimester. None had clinical evidence of thyroid disease and all had normal serum TSH concentrations.
Thyroxine replacement therapy Fifty-eight patients were studied. All had received a constant dose of thyroxine for at least 2 months for spontaneous or 13lI-induced primary hypothyroidism. Twenty patients, with undetectable serum TSH concentrations ( < 0·1 mUlL), were regarded as over-treated with T 4 • Nineteen had normal serum TSH concentrations (between 0·3 and 5·0 mUlL) and were considered to be adequately replaced on T 4 and 19 patients with raised TSH concentrations ( > l2mU/L) were considered to' be underreplaced.
Non-thyroidal Illness and drugs Ninety-eight patients admitted consecutively to a general medical ward were studied. Two patients were taking thyroxine for primary hypothyroidism and in one patient a diagnosis of primary hypothyroidism was made on admission. In the remaining 95 patients there was no history of thyroid disease. All patients had TSH and total Tl concentrations measured in addition to free T4 · We also investigated 61 patients with chronic renal failure who were being treated by dialysis. Plasma creatinine concentrations ranged from 700 to 1500j.lmol/L. Samples for analysis were taken before dialysis.
Fifty-five patients being treated with either phenytoin or carbamazepine for the treatment of epilepsy were also studied.
MATERIALS AND METHODS
Two-step method for free T4 Free T 4 concentrations were measured using a non-isotopic two-step assay with reagents, lyophilized standards and pools supplied by Celltech Diagnostics Ltd, Cambridge, UK.
All procedures were carried out in duplicate at room temperature. Sample (20 j.lL) was dispensed with 200 j.ll of incubation buffer into microtitre wells that had been coated with antibody to T 4 • The samples were incubated with agitation for 30 min, the wells were then aspirated and the plate washed once with buffer. Next biotinlabelled T 4 (lOOj.lL) was added to the wells and incubated for 15min with agitation after which time 100 j.lL of streptavidin-horseradish peroxidase conjugate was added and the sample incubated for a further 15min. The wells were aspirated and washed four times with buffer. Substrate in buffer was added (200j.lL) and the plate agitated for 15min. The optical density of the blue colour developed was read at two wavelengths (630 and 492 nm) and the standard curve, free T 4 values and precision profile were derived using software supplied by Celltech Diagnostics.
Within-assay precision for the two-step method was assessed using either precision profiles derived using duplicates of standards or by four serum pools assayed in duplicate on a single plate at least eight times. Between-assay precision was derived from the four pools run on 27 occasions.
The sensitivity of the assay and the mean working range (defined as the dose range having a coefficient of variation of < 10%) was calculated from 27 consecutive assays. Drift was assessed by repeat analysis of the four pools across an assay plate.
The effects of serum dilution of free T 4 concentration was investigated by measuring free T 4 in samples from four patients (two euthyroid, Two-step free thyroxine immunoassay 583 one pregnant, one taking the oral contraceptive pill) after the samples had been diluted x I, x 1,3, x 2, x 4, x 8 and x 16 with 50 mrnol/L sodium phosphate buffer containing 140mrnol/L NaCI pH 7·5. These dilutions are equivalent to final dilutions of x II, x 14,3, x 22, x 44, x 88 and x 176, respectively. After dilution the samples were left at room temperature to equilibrate for I h prior to being assayed in duplicate.
A comparison was also made of free T 4 concentrations in 20 matched samples of serum, heparinized plasma and EDTA plasma.
Analogue RIA Free T 4 was measured by an isotopic analogue RIA method (Amerlex M, Amersham International, Buckinghamshire, UK). The reference range of 9-23 pmol/L was derived from 97 patients attending a thyroid clinic who were clinically and biochemically euthyroid and who had a normal TSH response to TRH injection. We have shown previously that the reference range obtained using the Amerlex M method was not significantly different from the reference range obtained using the original AmerIex kit. 2 The within-assay coefficient of variation (CV) was assessed from precision profiles and the betweenassay precision was determined from three serum pools run on 16 occasions.
Other analytes TSH was measured using a sensitive imrnunoradiometric assay (SimuITRAC; Becton Dickinson Diagnostics, Cowley, UK) that had a detection limit of 0·1 mUlL. Total T 4 and T', were measured using an in-house double antibody RIA l 1 with reference ranges of 70-150 and 1·2-2·9 nrnol/L, respectively. TSH receptor antibodies were quantitated by a kit method (RSR Ltd, Pentwyn, UK) and classified as positive if a value > 7 U /L was obtained.
RESULTS

Assay precision, drift and sensitivity
Withinand between-assay precision data for the two-step assay are shown in Table 1 . The withinassay precision assessed for the two-step assay using the mean of 10 precision profiles was worse than when within-assay precision was assessed using repeated determinations of four pools across a single assay plate. No evidence of any significant within-assay drift could be observed by repeat analysis of the four pools. The between-assay precision for the two-step assay was poor, having coefficients of variation between Amerlex M analogue RIA Between-assay (n = 16)
·Data from Novo Nordisk Diagnostics Ltd.
9·7% and 19·3% over a concentration range of 5·0 to 46 pmol/L; a coefficient of variation of < 8% was achieved both within and between batch for analogue RIA over a similar concentration range. The sensitivity of the two-step assay derived from 27 consecutive assays and calculated as the dose which was significantly different than zero using duplicate assays was 2·04 ± 0·94 prnol/L (mean ± SD); the mean working range (CV < 10%) derived from these same 27 assays was 4·3 to 76·0 pmol/L.
Effects of sample dilution
The effects of sample dilution as measured by the two-step assay are shown in Table 2 . It was necessary to dilute samples to a final dilution of 88-fold or more to produce a 50% reduction in free T 4 concentrations in the four sera investigated.
Serum/plasma differences Using a paired Student t-test no significant differences were found between free T 4 concentrations in 20 matched samples of serum, heparinized plasma or EDTA plasma. Concentrations obtained were (mean, (SD» 15·0 (2'24), 14·2 (2'29) and 14·9 (2'63) pmol/L, respectively.
Thyroid clinic patients (Fig. 1 ) The reference range (95% confidence limits) of 7 to 20 pmol/L obtained for the two-step method
. . Patients with abnormal binding proteins ( Fig. 3 ) Familial dysalbumineamic hyperthyroxinaemia Free T 4 concentrations were elevated in all patients by analogue RIA (in the range 27-> 77 pmol{L) (diagnostic specificity 0%), whereas, only eight patients had elevated free T 4 by the two-step method (in the range 21-30 pmol/L) (diagnostic specificity 52%).
TBG abnormalities
There was a marked scatter of free T 4 results in patients with TBG excess when measured by the analogue RIA and seven of the 12 patients had raised free T 4 values by this method, whereas the two-step method gave results within the reference range in all 12 patients. In the single patient we studied with TBG deficiency, the free T 4 concentration found by analogue RIA was sub-normal, although it was normal by the two-step method.
Overall the diagnostic specificities for the twostep and analogue RIA were 100% and 38%, respectively.
T. autoantibodies
In patients with T 4 autoantibodies, analogue free T 4 data were only available on four patients; in each case free T 4 values were significantly elevated, consistent with increased binding of tracer by T4 autoantibodies. In three of these four patients free T 4 was modestly raised by the twostep method, and in one patient a normal free T 4 concentration was found. Of the five patients in whom analogue free T 4 values were not available, two had raised free T4 and three had normal free T 4 by the two-step method.
Pregnancy (Fig. 4 ) A significant (P < 0'001) decrease in free T 4 was found between the first and third trimesters of pregnancy with both the two-step and analogue RIA methods. Normal free T 4 concentrations were found in all women during the first and second trimester but in the third trimester low or equivocal free T 4 concentrations were found in three women by the two-step method and six women by analogue RIA. Using reference ranges derived from non-pregnant euthyroid individuals the diagnostic specificity of the two-step and analogue RIA were 100% and 93%, respectively. Non-thyroidal illness and drugs ( Fig. 5 ) Non-thyroidal illness Free T 4 concentrations by the two-step method were elevated in 12 of the 98 patients presenting to a general medical ward. Two of these 12 patients also had suppressed TSH ( < 0·1 mU/ L) but total T J concentrations were normal in both; both patients were clinically euthyroid (the reasons for admission were a road traffic accident and hypothermia). Of the remaining 10 patients with raised free T 4 concentrations by the two-step methods all were clinically euthyroid, had normal TSH and analogue RIA free T4 concentrations and normal or reduced total T J concentrations.
Only one patient had a subnormal free T 4 concentration when measured by the two-step method. This patient had a TSH of 20'8mU/L and a total T] of 0·5 nmol/L, and was subsequently diagnosed as having primary hypothyroidism.
When free T 4 was measured by analogue RIA in the same 98 patients, only three patients had elevated concentrations of free T 4 • One of these patients was the patient described above with hypothermia and repeat analysis of the sample with an alternative analogue RIA method (SimuITRAC, Becton Dickinson Diagnostics, Cowley, UK) also produced an elevated result. In the other two patients in whom Amer/ex free T 4 values were 29 and 24 pmol/L, respectively, normal concentrations of free T 4 were found by the SimulTRAC method, consistent with the normal TSH concentration found in both patients. Subnormal free T 4 concentrations were obtained in 10 patients, one of whom had primary hypothyroidism and a raised TSH concentration. The diagnostic specificities of the two-step and analogue RIA methods were both 88%.
Chronic renal failure Free T 4 concentrations measured by the two-step method and by analogue RIA were subnormal in six (diagnostic specificity 90%) and 33 patients (diagnostic specificity 46%), respectively. By both methods, free T 4 concentrations were significantly lower (P < 0·001) than in euthyroid patients attending the thyroid clinic.
Anti-epileptic drugs
All 55 patients had normal free T 4 concentrations by the two-step method (diagnostic specificity 100%), whereas 13 patients receiving phenytoin or carbamazepine had subnormal free T 4 concentrations by analogue RIA (diagnostic specificity 76%).
DISCUSSION
The two-step method gave good discrimination of overt thyroid dysfunction in the patients attending the thyroid clinic although its failure to identify minor or subclinical forms of thyroid dysfunction indicates that it is less effective than a sensitive TSH measurement for defining thyroid status. The reference range for the twostep method, derived from the 112 euthyroid patients, was also lower than the reported reference ranges for many of the analogue methods.' Free T 4 concentrations in pregnancy were similar by analogue RIA and the two-step method and confirm previous findings by analogue RIA. I 4-' 7 A significant decrease in free T 4 occurs as pregnancy progresses and this is also apparent when the reference method of equilibrium dialysis is used." In the present study, free T 4 concentrations by the two-step method during the third trimester were within the reference range which is consistent with free T 4 obtained using equilibrium dialysis." The finding of equivocal or subnormal free T 4 in some pregnant women confirms several previous reports and has been attributed to a true fall in free T 4 during pregnancy, and an artefactual lowering of free T 4 associated with reduced albumin levels. 1 4-17 The data (Fig. 4) . show that trimester-related reference ranges should be provided irrespective of the method used for free T 4 measurement.
Most patients who were overtreated with thyroxine had elevated free T 4 concentrations but Two-step free thyroxine immunoassay 589 patients with normal TSH concentrations showed a wide range of free T 4 concentrations; for example, 40% of patients had elevated free T4 associated with normal TSH concentrations. Furthermore, most patients receiving inadequate thyroxine replacement had normal free T 4 concentrations. These data suggest that, irrespective of the methodology used, free T 4 measurements are less reliable than TSH measurements to monitor adequacy of thyroxine replacement." Our finding of normal free T 4 concentrations by the two-step method in euthyroid patients with elevated TBG is consistent with this method being less dependent on the TBG concentration than the analogue RIA. 18 ,22.3o In FDH, free T 4 concentrations by two-step assay were considerably lower than by analogue RIA, although still elevated in eight of 17 patients. Whether this reflects an unrecognized method-related artefact in two-step assays or a reflection of the true thyroid status in FDH is unclear. The latter possibility is inconsistent with the normal TSH concentrations in FDH measured by ourselves and others. 18 ,19,30 In patients with T 4 autoantibodies elevated free T 4 concentrations were found by the two-step method in approximately half of the patients. Since most of these patients were being treated for a known thyroid disorder it is difficult to decide whether the free T 4 results were consistent with thyroid status.
Non-thyroidal illness and drug therapy are conditions which commonly present difficulties in the interpretation of thyroid function tests. 23 -28 ,34-38 Abnormal thyroid function tests are more commonly associated with nonthyroidal illness than thyroid disease." We observed two patterns of free T 4 results in patients with NT! when the two different assay procedures were employed. The analogue RIA gave a high prevalence of low free T 4 concentrations. This has been well described and is in part attributed to an artefact produced by low albumin concentrations and substances that inhibit the binding of analogue to albumin.s-11 , 35, 36 In contrast the two-step assay gave elevated free T 4 concentrations in 12 patients. This finding of elevated free T 4 concentrations in non-thyroidal illness is in agreement with equilibrium dialysis data and is thought to be caused by an increase in endogenous inhibitors of thyroxine binding. 5 ,36,37 Very low levels of free T 4 were found in patients with chronic renal failure by the analogue RIA and yet these patients were euthyroid with normal TSH concentrations." In contrast the two-step method gave normal free T 4 concentrations in most of these patients but the mean concentration was still significantly lower (9, 8 pmol/L) than in the euthyroid group (13·4pmol/L). This conflicts with data obtained by direct equilibrium dialysis where normal or slightly raised concentrations are found in chronic renal failures and reflects pre-dilution of sample which, in turn, affects the concentration of inhibitors of protein binding.
Although the two-step method showed the desired characteristics of a free T 4 assay, in that specimen dilution had little effect on the measured free T 4 concentration, the betweenassay precision was poor and unacceptable for routine use.
The Celltech free T 4 assay has now undergone re-development by Novo Nordisk Diagnostics Ltd mainly to improve precision. Overall assay performance has been improved by re-optimization of plate coating conditions and by changing the assay buffers in line with a changed detection system. The assay protocol has also been modified reducing 'hands-on' time and eliminating the need for shaken incubations. In the modified assay thyroxine has been conjugated directly to an alkaline phosphatase label which is detected by a two-stage enzyme amplification system." These modifications have been made without altering the immunological basis or apparently changing the clinical characteristics of the original assay. The between-assay precision obtained by Novo Nordisk Diagnostics Ltd using this modified assay is shown in Table  1 .
In conclusion, we have shown that the twostep non-isotopic method provides a rapid, reliable estimate of free T4 in a wide range of clinical conditions. Its diagnostic specificity is superior to that of an analogue RIA method particularly in patients with abnormal T 4 binding proteins or in the presence of factors which affect the binding of T4' The two-step method we used is less precise than an analogue RIA method but with the modification of the assay described above it would appear now to have satisfactory precision.
